Diligence memo · auto-generated · as of July 2, 2026
AesRx, LLC
AesRx, LLC looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
AesRx, LLC operates in Biotechnology, based in NEWTON.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
AesRx, LLC has raised $8.1M in disclosed capital across 8 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $1.5M on 2011-05-06.
Most recent recorded round closed around 2013-11-25.
Valuation (modeled)modeled
Provath models AesRx, LLC at approximately $27M (range $432K–$209M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.40× the median modeled value of Seed Biotechnology companies in 2013–2015 (122 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 4 months.
Last raise 12.6 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round was 2.3× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 52% of Biotechnology peers (4291 compared).
Modeled value ranks above 33% of those peers.
Closest niche peers: Harpoon Medical, Inc., Admittance Technologies, Inc., Bell Biosystems, Inc., Nexstim Plc, Iontera, Inc..
Peoplefiled
6 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.